Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database

por Campillo, Jeremy T., Faillie, Jean-Luc
Publicado 2022

Diabète et COVID-19

por Bouhanick, Béatrice, Cracowski, Jean-Luc, Faillie, Jean-Luc
Publicado 2020

Diabetes and COVID-19

por Bouhanick, Béatrice, Cracowski, Jean-Luc, Faillie, Jean-Luc
Publicado 2020

DPP-4 inhibitors and severe course of illness in patients with COVID-19

por Bouhanick, Béatrice, Cracowski, Jean-Luc, Faillie, Jean-Luc
Publicado 2021

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study

por Faillie, Jean-Luc, Azoulay, Laurent, Patenaude, Valerie, Hillaire-Buys, Dominique, Suissa, Samy
Publicado 2014

Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World

por Campillo, Jérémy T., Boussinesq, Michel, Bertout, Sébastien, Faillie, Jean-Luc, Chesnais, Cédric B.
Publicado 2021

Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study

por Campillo, Jérémy T., Eiden, Céline, Boussinesq, Michel, Pion, Sébastien D. S., Faillie, Jean‐Luc, Chesnais, Cédric B.
Publicado 2021

Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study

por Mathieu, Clément, Pambrun, Elodie, Bénard-Laribière, Anne, Noize, Pernelle, Faillie, Jean-Luc, Bezin, Julien, Pariente, Antoine
Publicado 2022

Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study

por Diaz, Laurine, Jauzelon, Benjamin, Dillies, Anne-Charlotte, Le Souder, Cosette, Faillie, Jean-Luc, Maria, Alexandre Thibault Jacques, Palassin, Pascale
Publicado 2023

Comprehensive description of adult-onset Still's disease after COVID-19 vaccination

por Palassin, Pascale, Bres, Virginie, Hassan, Samaher, Alfonsi, Ange, Massy, Nathalie, Gras-Champel, Valérie, Maria, Alexandre Thibault Jacques, Faillie, Jean-Luc
Publicado 2023

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study

por Abrahami, Devin, Douros, Antonios, Yin, Hui, Yu, Oriana HY, Faillie, Jean-Luc, Montastruc, François, Platt, Robert W, Bouganim, Nathaniel, Azoulay, Laurent
Publicado 2018

Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)

por Laroche, Marie‐Laure, Gautier, Sophie, Polard, Elisabeth, Rabier, Marie‐Blanche, Chouchana, Laurent, Lebrun‐Vignes, Bénédicte, Faillie, Jean‐Luc, Petitpain, Nadine, Lagarce, Laurence, Jonville‐Bera, Annie‐Pierre
Publicado 2022

Management of Gastro-Intestinal Toxicity of the Pi3 Kinase Inhibitor: Optimizing Future Dosing Strategies

por Breal, Claire, Beuvon, Frederic, de Witasse-Thezy, Thibault, Dermine, Solene, Franchi-Rezgui, Patricia, Deau-Fisher, Benedicte, Willems, Lise, Grignano, Eric, Contejean, Adrien, Bouscary, Didier, Faillie, Jean Luc, Treluyer, Jean-Marc, Guerin, Corinne, Chouchana, Laurent, Vignon, Marguerite
Publicado 2023

Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series

por Coustal, Cyrille, Vanoverschelde, Juliette, Quantin, Xavier, Lesage, Candice, Michot, Jean-Marie, Lappara, Ariane, Ederhy, Stephane, Assenat, Eric, Faure, Maxime, Issa, Nahema, Lambotte, Olivier, Puyade, Mathieu, Dereure, Olivier, Tosi, Diego, Rullier, Patricia, Serre, Isabelle, Larcher, Romaric, Klouche, Kada, Chanques, Gérald, Vernhet-Kovacsik, Hélène, Faillie, Jean-Luc, Agullo, Audrey, Roubille, François, Guilpain, Philippe, Maria, Alexandre Thibault Jacques
Publicado 2023